Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		91 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014
Operating activities
Net loss	$ (1,572,977)	$ (1,767,192)	$ (9,596,237)
Adjustments to reconcile net income to net cash provided (used) by operating activities
Depreciation	25,488	25,488	227,670
Change in allowance for uncollectible note receivable			38,867
Amortization of deferred financing costs			59,605
Interest (income) expense on fair value adjustment	354,451	(23,556)	992,739
Loss on extinguishment of debt			381,113
Write-off of uncollectible deposits			20,000
Accrued interest on note receivable			(11,705)
Loss on impairment	1,100		43,900
Amortization of beneficial conversion feature of the notes payable	270,640	106,358	270,638
Common stock issued for services	185,799	1,024,491	3,167,196
Common stock issued for legal services		56,928	122,423
Common stock issued for financing fees			5,000
Decrease (increase) in:
Prepaid expenses	13,447	13,559	(25,623)
Advances from shareholder		(2,500)	(1,015)
Deposits and other receivables			(23,346)
Decrease in advance to shareholder	3,267		3,267
Accounts payable and accrued expenses	33,782	86,162	268,296
Net cash provided (used) by operating activities	(685,003)	(480,262)	(4,057,214)
Cash flows from investing activities:
Principal payments from notes receivable			(25,000)
Purchase of common stock			(34,100)
Property and equipment acquisitions			(325,000)
Net cash provided (used) by investing activities			(384,100)
Cash flows from financing activities:
Proceeds from the issuance of common stock	329,496	241,343	2,655,383
Proceeds from the issuance of convertible notes payable	335,505	169,500	1,401,305
Proceeds from the issuance of convertible notes payable, related party	60,505	55,500	260,507
Proceeds from issuance of notes payable			286,500
Proceeds from issuance of notes payable, related parties			8,500
Payments on convertible notes payable		(30,000)	(76,000)
Payments on notes payable			(57,500)
Payments on notes payable, related parties		7,500	(1,000)
Proceeds from loans from stockholders			49,675
Payments on loans from stockholders		(7,500)	(44,975)
Net cash provided by financing activities	725,506	436,343	4,482,664
Net increase (decrease) in cash	40,772	(43,919)	41,350
Cash - beginning	578	43,919
Cash - ending	41,350		41,350
Supplemental disclosure of cash flow information:
Cash paid for interest expense			3,660
Cash paid for income taxes
Noncash operating and financing activities:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued in connection with a joint venture			9,800
Common stock issued to satisfy debt	7,683		140,870
Common stock issued to satisfy minimum value guaranteed			87,667
Convertible debt and accrued interest converted to common stock	364,932	143,936	1,874,532
Common stock issued in exchange for property and equipment			$ 7,420